LSD microdosing in major depressive disorder: results from an open-label trial
{{output}}
Major depressive disorder (MDD) affects approximately 5 % of the global population. Classic psychedelics have shown promise in treating various mental health disorders. This study evaluated the feasibility and tolerability of an 8-week regimen of microdosed ly... ...
